|

WBF-038 Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Akkermansia muciniphila/Anaerobutyricum hallii/Bifidobacterium infantis/Clostridium beijerinckii/Clostridium butyricum/Inulin WBF-038, Pendulum WBF-038 (SY), Probiotic/Prebiotic Formulation WBF-038 (SY), Synbiotic Formulation WBF-038 (SY), WBF 038 (CN) +2 more

Pipeline

Phase 2: 1

Top Sponsors

  • Mayo Clinic1

Indications

  • Anatomic Stage 0 Breast Cancer AJCC v81
  • Hormone Receptor Positive Breast Carcinoma1
  • Anatomic Stage III Breast Cancer AJCC v81
  • Anatomic Stage II Breast Cancer AJCC v81
  • Anatomic Stage I Breast Cancer AJCC v81

Jacksonville, Florida1 trial

5-strain Probiotic Formulation in HR-positive Breast Cancer Receiving Aromatase Inhibitor to Prevent Bone Loss

Mayo Clinic in Florida

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.